Primary Lesion Treatment for Bone Metastases

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-31

Study Completion Date

2026-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will carry out a prospective cohort study to study the effect of different primary leison treatment modes on disease control, quality of life, economic cost and survival period of patients with bone metastases from breast cancer and lung cancer by giving radiotherapy or palliative surgery or not giving local treatment for the primary lesion in patients with bone metastases from breast cancer or lung cancer

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

CTC in Lung Caner Patients With Bone Metastases

NCT04568291

Lung Cancer Bone Metastases Single Cell Sequencing Technology

UNKNOWN NA

Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC

NCT03614065

Non-small Cell Lung Cancer

UNKNOWN PHASE2

An Observational Study to Explore Clinical Characteristics of the Patients With T1 Non-small Cell Lung Cancer

NCT03413956

Non Small Cell Lung Cancer

COMPLETED

Study on Clinical Features, Treatment Mode and Survival of Bone and Soft Tissue Tumors

NCT05468970

Bone and Soft Tissue Tumors Clinical Features

RECRUITING

A Real-world Study on the Treatment of Non-small Cell Lung Cancer With Leptomeningeal Metastasis in China

NCT06718972

Meningeal Metastasis Non-Small Cell Lung Cancer

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bone Metastases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

radiotherapy

Group Type EXPERIMENTAL

radiotherapy

Intervention Type RADIATION

radiotherapy

palliative surgery

Group Type EXPERIMENTAL

palliative surgery

Intervention Type PROCEDURE

palliative surgery

no primary leison treatment

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

radiotherapy

Intervention Type RADIATION

palliative surgery

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. HR positive breast cancer patients with bone metastasis or Non-small-cell lung cancer patients with bone metastasis；
2. Aged over 18;
3. ECOG：0-1；
4. Patients who benefit clinically(CR+PR) after 6 months of treatment.

Exclusion Criteria

1. The expected life span is less than 3 months;
2. Have serious cardiovascular and cerebrovascular diseases, blood coagulation dysfunction, and cannot tolerate surgery;
3. Allergies to narcotic drugs;
4. The patient refused the treatment decision of the integrated team.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No